The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

Share Price Information for Enteq Tech (NTQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.50
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 1.00 (11.765%)
Open: 9.00
High: 9.00
Low: 9.00
Prev. Close: 9.00
NTQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-end Trading Update

7 Apr 2022 07:00

RNS Number : 5472H
Enteq Technologies PLC
07 April 2022
 

 

 

 

Enteq Technologies plc

("Enteq")

Year-end Trading Update

 

 

Enteq Technologies plc (AIM: NTQ.L) the energy services technology supplier is pleased to announce a trading update for the financial year ended 31 March 2022.

 

Market recovery has resulted in revenues above expectations and adjusted EBITDA1 in-line. SABER2 technology development continues to be on-track, with sufficient cash to take it through commercialisation in 2022.

 

Trading Update

The North American benchmark ("WTI") oil price per barrel rose from around $63 in April 2021, at the start of the financial year to around $92 in March 2022, with the North American active rig count steadily increasing throughout the year from 430 to approximately 670 in March 2022. International recovery in active rig count started to increase approximately six months after the North American market, as expected.

 

Enteq's reported revenue for the second half of the financial year will be in the region of $4.9m, a significant increase over the $2.3m achieved in the first half. Revenue for the full year ended 31 March 2022, will thus be in the region of $7.2m, ahead of the Board's previous expectations.

 

The international market (excluding China) started to recover in the second half of the financial year, with equipment being delivered to a new customer in Central Asia. Since the beginning of the hostilities towards Ukraine, Enteq has not been doing business with Russia, with minimal business impact. A delayed recovery in China has been offset by an increase in revenues from North American activity.

 

Adjusted EBITDA for the year is expected to be $0.3m, in-line with expectations. The gross margin reflects a sales mix now including an increase in revenues relating to third-party technology partnership agreements. The cash balance as at 31 March 2022 was $4.9m ($5.3m as of 30 September 2021, $8.1m as of 31 March 2021) reflecting the scheduled on-going investment in technologies throughout the year, primarily the SABER technology development.

 

 

Technology Investment

Testing has demonstrated that SABER's unique steering concept can generate sufficient steering forces to perform effectively. Therefore, this simple and lower cost to operate system has the potential to offer efficiency improvements and to disrupt the current market. The system has applications in geothermal, oil and gas and methane capture, with the oil and gas RSS market being over $1.9bn annually.

 

The SABER system is on-track for commercialisation during 2022, with existing resources in place to complete the remaining phase of the development project.

 

 

The Company expects to announce its results for the year ended 31 March 2022 on 6 July 2022.

 

 

Enteq Technologies plc +44 (0) 20 8087 2202

www.enteq.com 

Andrew Law, Chief Executive Officer

David Steel, Chief Financial Officer

 

finnCap Ltd (NOMAD and Broker) +44 (0) 20 7220 0500

Ed Frisby, Emily Watts, Tim Harper (Corporate Finance)

Andrew Burdis, Barney Hayward (ECM)

 

 

The financial information for FY22 included in this announcement is unaudited.

 

 

1 Adjusted EBITDA is reported profit before tax adjusted for interest, depreciation, amortisation, foreign exchange movements, performance share plan charges and exceptional items.

 

2 SABER (Steer-At-Bit Enteq Rotary Tool), a potential 'game changer' compared to current rotary steerable systems available, enables Enteq to enter the Rotary Steerable Drilling service market which has an estimated world-wide annual value of over $1.9bn in 2022, of which approximately 40% is accessible by the SABER Tool technology.

 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKABKOBKDFQK
Date   Source Headline
10th Apr 20247:00 amRNSYear-end Trading Update
11th Jan 20249:12 amRNSHolding(s) in Company
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.